Predictors of Severe COVID-19 Outcomes

  • STATUS
    Recruiting
  • participants needed
    1500
  • sponsor
    Verily Life Sciences LLC
Send
Updated on 16 February 2024
See if I qualify
respiratory distress
covid-19
acute respiratory distress

Summary

This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. We seek to understand whether there are early signatures that predict progression to ARDS, mortality, and/or other comorbid conditions. The duration of the study participation is approximately 3 months.

Details
Condition Pulmonary Disease, ADULT RESPIRATORY DISTRESS SYNDROME, Covid 19
Age 21years - 100years
Clinical Study IdentifierNCT04388813
SponsorVerily Life Sciences LLC
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Participant or legally authorized representative willing and able to provide informed consent
Receiving care at a participating hospital
Age 21 years old or older
U.S. Resident
Patient classified as a Person Under Investigation (PUI) for COVID-19 or is confirmed positive for COVID-19
Willing and able to comply with all study procedures

Exclusion Criteria

Pregnancy
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

respiratory distress
covid-19
acute respiratory distress

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.